Abstract
Rights: UNKNOWN · https://www.elsevier.com/tdm/userlicense/1.0/ · Source: journal-auto-sync:external:CROSSREF_ISSN
Christopher James Zeitz
Abstract
Rights: UNKNOWN · https://www.elsevier.com/tdm/userlicense/1.0/ · Source: journal-auto-sync:external:CROSSREF_ISSN
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction
1986
Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2
1988
An international randomized trial comparing 4 thrombolytic strategies for acute myocardial infarction
10.1056/nejm199309023291001 · 1993
Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients
10.1016/s0140-6736(94)91161-4 · 1994
The effects of tissue plasminogen activator, streptokinase, or both on coronary artery patency, ventricular function and survival after acute myocardial infarction
10.1056/nejm199311253292204 · 1993
The thrombolysis in acute myocardial infarction (TIMI) trial: phase I findings
10.1056/nejm198504043121437 · 1985
Applying the open artery theory: use of predictive survival markers
10.1053/euhj.1998.1017 · 1998
Variations in patient management and outcomes for acute myocardial infarction in the United States and other countries
10.1001/jama.1995.03520440040034 · 1995
Community hospital administration of intravenous tissue plasminogen activator in acute myocardial infarction: improved timing, thrombolytic efficacy and ventricular function
10.1016/s0735-1097(87)80114-6 · 1987
Illusion of reperfusion. Does anyone achieve optimal reperfusion during acute myocardial infarction?
10.1161/01.cir.88.3.1361 · 1993
Randomized comparison of rescue angioplasty with conservative management of patients with early failure of thrombolysis for acute myocardial infarction
10.1161/01.cir.90.5.2280 · 1994
Evaluation of thrombolytic therapy and timing of cardiac catheterization in acute myocardial infarction. Results of thrombolysis and angioplasty in myocardial infarction-phase 5 randomized trial
10.1161/01.cir.83.5.1543 · 1991
Significance of a coronary artery with thrombolysis in myocardial infarction grade 2 flow “patency” (outcome in the thrombolysis and angioplasty in myocardial infarction trials). Thrombolysis and angioplasty in myocardial infarction study group
10.1016/s0002-9149(99)80678-x · 1995
Acute coronary thrombolysis with recombinant human tissue-type plasminogen activator: initial patency and influence of maintained infusion on reocclusion rate
10.1016/0002-9149(87)90219-0 · 1987
and the Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group. A randomised trial of immediate versus delayed angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction
10.1056/nejm198709033171001 · 1987
A systemic non-lytic state and local thrombolytic failure of anistreplase (anisoylated plasminogen streptokinase activator complex [APSAC]) in acute myocardial infarction
10.1136/hrt.64.6.355 · 1990
Systemic lytic state is not a predictor of coronary reperfusion in acute myocardial infarction
10.1016/s0167-5273(96)02780-5 · 1996
Relation of plasma lipoprotein(a) to infarct artery patency in survivors of myocardial infarction
10.1161/01.cir.88.3.935 · 1993
Increased thrombin levels during thrombolytic therapy in acute myocardial infarction: relevance for unsuccessful therapy
10.1161/01.cir.83.3.937 · 1991
Usefulness of fibrogenolytic and procoagulant markers during thrombolytic therapy in predicting clinical outcomes in acute myocardial infarction: thrombolysis in acute myocardial infarction
10.1016/s0002-9149(96)00353-0 · 1996
Prognostic role of plasminogen-activator-inhibitor-1 levels in treatment with streptokinase of patients with acute myocardial infarction
10.1002/clc.4960230723 · 2000
Lack of influence of pretreatment antistreptokinase antibody on efficacy in a multicenter patency comparison of intravenous streptokinase and anistreplase in acute myocardial infarction
10.1016/0002-8703(92)90591-i · 1992
Acute myocardial infarction: failed thrombolysis
10.1136/heart.85.1.104 · 2001
Necropsy evaluation in seven patients with evolving acute myocardial infarction treated with thrombolytic therapy
10.1016/0002-9149(84)90243-1 · 1984
Influence of plaque configuration and stress distribution on fissuring of atherosclerotic plaques
10.1016/s0140-6736(89)90953-7 · 1989
Characteristics and outcome of patients in whom reperfusion with intravenous tissue-type plasminogen activator fails: results of the thrombolysis and angioplasty in myocardial infarction (TAMI) I trial
10.1161/01.cir.77.5.1090 · 1988
Early noninvasive identification of failed reperfusion after intravenous thrombolytic therapy in acute myocardial infarction
10.1016/s0735-1097(98)00139-9 · 1998
Zwolle myocardial infarction study group: clinical value of a 12-lead electrocardiogram after successful reperfusion therapy for acute myocardial infarction
10.1016/s0140-6736(96)07120-6 · 1997
Acute myocardial infarction: thrombolysis
10.1136/heart.83.1.122 · 2000
ST-Segment recovery as an endpoint in acute myocardial infarction trials: past, pres-ent, and future
1993
Intermittent coronary occlusion in acute myocardial infarction. Value of combined thrombolytic and vasodilator therapy
10.1056/nejm198710223171704 · 1987
Continuously updated 12-lead ST-segment recovery analysis for myocardial infarct artery patency assessment and its correlation with multiple simultaneous early angiographic observations
10.1016/0002-9149(93)90729-v · 1993
Noninvasive assessment of speed and stability of infarct-related artery reperfusion: results of the GUSTO ST-segment monitoring study
10.1016/0735-1097(95)00110-p · 1995
Angiographic validation of bedside markers of reperfusion
10.1016/0735-1097(93)90716-e · 1993
Myocardial perfusion patterns related to thrombolysis in myocardial infarction perusion grades after coronary angioplasty in patients with acute anterior wall myocardial infarction
10.1161/01.cir.93.11.1993 · 1996
The clinical implications of no reflow demonstrated with intravenous perfluorocarbon containing microbubbles following restoration of thrombolysis in myocardial infarction (TIMI) 3 flow in patients with acute myocardial infarction
10.1016/s0002-9149(98)00597-9 · 1998
Noninvasive detection of coronary artery patency using continuous ST-segment monitoring
10.1016/0002-9149(86)90730-7 · 1986
Prognostic implications of TIMI flow grade in the infarct related artery compared with continuous 12-lead ST-segment resolution analysis
10.1016/s0735-1097(99)00601-4 · 2000
Prediction of infarct coronary artery recanalization after intravenous thrombolytic therapy
10.1016/0002-9149(87)91158-1 · 1987
Changes in stand-ard electrocardiographic ST-segment elevation predictive of successful reperfusion in acute myocardial infarction
10.1016/0002-9149(90)90524-5 · 1990
Intra-aortic balloon pumping as adjunctive therapy to rescue coronary angioplasty after failed thrombolysis in anterior wall acute myocardial infarction
10.1016/s0002-9149(99)80805-4 · doi-reference
Effectiveness of early coronary angioplasty and abciximab for failed thrombolysis (reteplase or alteplase) during acute myocardial infarction (results from the GUSTO-III trial). Global use of strategies to open occluded coronary arteries
10.1016/s0002-9149(99)00437-3 · doi-reference
Randomized trial of late elective angioplasty versus conservative management for patients with residual stenoses after thrombolytic treatment of myocardial infarction. Treatment of post-thrombolytic stenoses (TOPS) study group
10.1161/01.cir.86.5.1400 · doi-reference
Recombinant tissue-type plasminogen activator and immediate angioplasty in acute myocardial infarction. One-year follow-up. The European Cooperative Study Group
10.1161/01.cir.86.1.111 · doi-reference
SWIFT trial of delayed elective intervention vs conservative treatment after thrombolysis with anistreplase in acute myocardial infarction
10.1136/bmj.302.6776.555 · doi-reference
Comparison of immediate invasive, delayed invasive, and conservative strategies after tissue-type plasminogen activator. Results of the thrombolysis in myocardial infarction (TIMI) phase II-A trial
10.1161/01.cir.81.5.1457 · doi-reference
The European Cooperative Study Group trial of intravenous recombinant tissue-type plasminogen activator (rt-PA) and conservative therapy versus rt-PA and immediate coronary angioplasty
10.1016/0735-1097(88)92637-x · doi-reference
Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) phase II trial
10.1056/nejm198903093201002 · doi-reference
Immediate vs delayed catheterization and angioplasty following thrombolytic therapy for acute myocardial infarction. TIMI II A results
10.1001/jama.1988.03410190097031 · doi-reference
A randomized trial of intravenous tissue plasminogen activator for acute myocardial infarction with subsequent randomization to elective coronary angioplasty
10.1056/nejm198712243172601 · doi-reference
A prospective, placebo-controlled, randomized trial of intravenous strepto-kinase and angioplasty versus lone angioplasty therapy of acute myocardial infarction
10.1161/01.cir.86.6.1710 · doi-reference
Prospective temporal analysis of the onset of preinfarction angina versus outcome: an ancillary study in TIMI-9B
10.1161/01.cir.97.11.1042 · doi-reference
Does ischaemic conditioning occur in patients?
10.1016/0735-1097(94)90880-x · doi-reference
Prodromal angina limits infarct size: a role for ischaemic preconditioning
10.1161/01.cir.91.2.291 · doi-reference
Effect on short-term prognosis in left ventricular function of angina pectoris prior to first Q-wave anterior wall infarction
10.1016/0002-9149(94)90428-6 · doi-reference
Toward a new frontier in myocardial reperfusion therapy: emerging platelet preeminence
10.1161/01.cir.97.2.211 · doi-reference
Features and outcome of no-reflow after percutaneous coronary intervention
10.1016/s0002-9149(99)80410-x · doi-reference
Ability of the no-reflow phenomenon during an acute myocardial infarction to predict left ventricular dysfunction at one-month follow-up
10.1016/s0002-9149(99)80250-1 · doi-reference
Absence of preinfarction angina is associated with a risk of no-reflow phenomenon after primary coronary angioplasty for a first anterior wall acute myocardial infarction
10.1016/s0167-5273(00)00340-5 · doi-reference
Failure of thrombolysis: experience with a policy of early angiography and rescue angioplasty for electrocardiographic evidence of failed thrombolysis
10.1136/heart.84.2.197 · doi-reference
Coronary angioplasty with or without stent implantation for acute myocardial infarction. Stent primary angioplasty in myocardial infarction study group
10.1056/nejm199912233412601 · doi-reference
Rescue angioplasty in the thrombolysis in myocardial infarction (TIMI) 4 trial
10.1016/s0002-9149(97)00277-4 · doi-reference
A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction
10.1056/nejm199303113281002 · doi-reference
Rescue PTCA following failed thrombolysis and primary PTCA: a retrospective study of angiographic and clinical outcome
10.1023/a:1008807321037 · doi-reference
Rescue thrombolysis: alteplase as adjuvant treatment after streptokinase in acute myocardial infarction
10.1136/hrt.74.4.348 · doi-reference
Early reperfusion assessment and repeated thrombolysis in acute myocardial infarction estimated by repeated standard electrocardiography, a randomised, double-blind, placebo-controlled pilot study
10.1159/000007047 · doi-reference
Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction
10.1161/01.cir.97.8.765 · doi-reference
Change in ST-segment elevation 60 minutes after thrombolytic initiation predicts clinical outcome as accurately as later electrocardiographic changes
10.1136/hrt.78.5.465 · doi-reference
Meta-analysis of five reported studies on the relation of early coronary patency grades with mortality and outcomes after acute myocardial infarction
10.1016/s0002-9149(96)00217-2 · doi-reference
Long-term prognosis of late spontaneous reperfusion after failed thrombolysis for acute myocardial infarction
10.1002/clc.4960221206 · doi-reference
Shifting the open-artery hypothesis downstream: the quest for optimal reperfusion
10.1016/s0735-1097(00)01101-3 · doi-reference
Time course and characteristics of ventricular arrhythmias after reperfusion in acute myocardial infarction
10.1016/0002-9149(87)90216-5 · doi-reference
Assessment of coronary artery patency after thrombolytic therapy: accurate prediction utilizing the combined analysis of three noninvasive markers
10.1016/s0735-1097(10)80215-3 · doi-reference
Reperfusion arrhythmia: a marker of restoration of antegrade flow during intracoronary thrombolysis for acute myocardial infarction
10.1016/0002-8703(83)90274-0 · doi-reference
Usefulness of the accelerated idioventricular rhythm as a marker for myocardial necrosis and reperfusion during thrombolytic therapy in acute myocardial infarction
10.1016/0002-9149(88)90921-6 · doi-reference
Three-year follow-up of patients with silent ischemia in the subacute phase of myocardial infarction after thrombolysis and early coronary intervention
10.1016/s0167-5273(99)00147-3 · doi-reference
Treatment of silent ischemia in unstable angina: a randomized comparison of sustained-release verapamil versus metoprolol
10.1002/clc.4960181112 · doi-reference
Acute heavy alcohol intake increases silent myocardial ischaemia in patients with stable angina pectoris
10.1136/hrt.75.6.563 · doi-reference
Prevalence, clinical characteristics, and mortality among patients with myocardial infarction presenting without chest pain
10.1001/jama.283.24.3223 · doi-reference
Rapid resolution of ST-segment elevation and prediction of clinical outcome in patients undergoing thrombolysis with alteplase (recombinant tissue plasminogen activator): results of the Israeli study of early intervention in myocardial infarction
10.1136/hrt.64.4.241 · doi-reference